ethyl pyruvate has been researched along with Carcinoma, Hepatocellular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Cheng, P; Dai, W; Guo, CY; Li, J; Lu, J; Shen, M; Wang, C; Wang, F; Xu, L; Yang, J; Zhang, H; Zhang, Y; Zheng, Y; Zhu, R | 1 |
1 other study(ies) available for ethyl pyruvate and Carcinoma, Hepatocellular
Article | Year |
---|---|
Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycation End Products, Advanced; Hep G2 Cells; HMGB1 Protein; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |